CURE Magazine Hosts #CureConnect Tweet Chat on Survivorship

8/28/18

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group’s flagship product, CURE® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, will be hosting its monthly Tweet Chat on Thursday, Aug. 30, at 1 p.m. EST, for readers to ask questions and to facilitate discussions about cancer survivorship.

“We look forward to hosting the next edition of the #CureConnect Tweet Chat, which will discuss patients’ stories and experiences about cancer survivorship,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group.

CURE® welcomes all patients and their loved ones, as well as health care professionals, advocates and nonprofit organizations to join the chat by using the hashtag #CureConnect. Topics of discussion during the Tweet Chat include:

  • Survivorship as a chronic illness.
  • Mental and emotional health.
  • Survivorship care planning.
  • Returning to “normal.”
  • Long-term side effects.

For more information, visit http://www.curetoday.com or find us on Twitter @cure_magazine or on Facebook @curemagazine.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, http://www.CUREtoday.com; innovative video programs, such as “CURE Connections®”; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers, as well as the dynamic website for oncology nurses, http://www.OncNursingNews.com, and its companion, Oncology Nursing News®magazine. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (http://www.www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.